NCT02206867View on ClinicalTrials.gov

Pharmacokinetics and Safety Study of LBAL in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy Subjects
Interventions
BIOLOGICAL

LBAL

Anti-inflammatory agents

BIOLOGICAL

Humira

Anti-inflammatory agents

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY

NCT02206867 - Pharmacokinetics and Safety Study of LBAL in Healthy Subjects | Biotech Hunter | Biotech Hunter